300 related articles for article (PubMed ID: 26488896)
1. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor-related headaches: a nationwide population-based case-crossover study in Taiwan.
Liang JF; Chen YT; Fuh JL; Li SY; Chen TJ; Tang CH; Wang SJ
Cephalalgia; 2015 Mar; 35(3):203-10. PubMed ID: 24853165
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
Lin SM; Yang SH; Liang CC; Huang HK
Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
[TBL] [Abstract][Full Text] [Related]
5. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.
Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ
Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors on pancreatic cancer risk and survival.
Kearns MD; Boursi B; Yang YX
Cancer Epidemiol; 2017 Feb; 46():80-84. PubMed ID: 28056391
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study.
Dai YX; Tai YH; Chen CC; Chang YT; Chen TJ; Chen MH
J Dermatol; 2020 Oct; 47(10):1126-1130. PubMed ID: 32613686
[TBL] [Abstract][Full Text] [Related]
8. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
[TBL] [Abstract][Full Text] [Related]
9. The association between proton pump inhibitor use and the risk of tuberculosis: A case-control study.
Song HJ; Park H; Park S; Kwon JW
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):830-839. PubMed ID: 30920070
[TBL] [Abstract][Full Text] [Related]
10. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
11. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy.
Liang CS; Bai YM; Hsu JW; Huang KL; Ko NY; Tsai CK; Yeh TC; Chu HT; Tsai SJ; Chen TJ; Chen MH
Seizure; 2021 Apr; 87():88-93. PubMed ID: 33735722
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA
Am J Gastroenterol; 2020 May; 115(5):706-715. PubMed ID: 32205645
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
15. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
16. Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population-Based Study.
Chen CH; Lee CZ; Lin YC; Kao LT; Lin HC
J Clin Pharmacol; 2019 Mar; 59(3):350-355. PubMed ID: 30329162
[TBL] [Abstract][Full Text] [Related]
17. Use of Proton Pump Inhibitors and the Risk of Listeriosis: A Nationwide Registry-based Case-Control Study.
Kvistholm Jensen A; Simonsen J; Ethelberg S
Clin Infect Dis; 2017 Apr; 64(7):845-851. PubMed ID: 28013257
[TBL] [Abstract][Full Text] [Related]
18. Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study.
Tran-Duy A; Connell NJ; Vanmolkot FH; Souverein PC; de Wit NJ; Stehouwer CDA; Hoes AW; de Vries F; de Boer A
J Intern Med; 2019 Feb; 285(2):205-214. PubMed ID: 30141278
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study.
Tseng HJ; Cheng CM; Tsai SJ; Lin WC; Bai YM; Tsai CF; Su TP; Li CT; Chen TJ; Chen MH
Cardiovasc Toxicol; 2021 Jun; 21(6):444-450. PubMed ID: 33625647
[TBL] [Abstract][Full Text] [Related]
20. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]